Novo Nordisk

Drugmaker seeks approval for China's first biosimilar Ozempic
Reuters
Wed, 04/3/24 - 11:07 am
Novo Nordisk
Ozempic
China
biosimilars
Hangzhou Jiuyuan Gene Engineering
Medicare Will Now Cover Weight-Loss Drug Wegovy
Forbes
Mon, 04/1/24 - 11:20 pm
Wegovy
Novo Nordisk
Medicare
Medicaid
Sanders Blasts Novo Nordisk for ‘Outrageous’ Price of Ozempic, Wegovy
BioSpace
Thu, 03/28/24 - 11:22 am
Novo Nordisk
Bernie Sanders
Ozempic
Wegovy
drug pricing
obesity
diabetes
Ozempic-like drugs linked to low, but increased risk of post-endoscopy pneumonia, study finds
Stat
Thu, 03/28/24 - 11:19 am
Ozempic
obesity
diabetes
Novo Nordisk
aspiration pneumonia
Eli Lilly
Nvidia's AI Tech Part of Novo Nordisk's New Supercomputer
Marketbeat
Tue, 03/26/24 - 11:32 am
Novo Nordisk
NVIDIA
artificial intelligence
supercomputer
Novo’s $1.1B Cardior buy continues expansion into heart disease
BioSpace
Mon, 03/25/24 - 11:39 am
Novo Nordisk
Cardior Pharmaceuticals
M&A
heart disease
Medicare to cover Novo’s weight-loss drug Wegovy for patients with heart disease
BioSpace
Fri, 03/22/24 - 10:58 am
Medicare
Novo Nordisk
weight loss
Wegovy
heart disease
Molecular glues are the latest craze in pharma research, but what are they?
Clinical Trials Arena
Thu, 03/21/24 - 06:38 pm
Novo Nordisk
molecular glue
R&D
Medicare Likely to Negotiate Prices for Obesity Drugs in Next Few Years: CBO
BioSpace
Thu, 03/21/24 - 11:18 am
Novo Nordisk
Wegovy
CBO
obesity
drug pricing
Riding GLP-1 wave, Novo Nordisk lays out $560M to boost drug production in China
Fierce Pharma
Tue, 03/19/24 - 09:26 pm
Novo Nordisk
China
drug manufacturing
Is Novo Nordisk on the Verge of Another Blockbuster Drug?
Motley Fool
Tue, 03/19/24 - 11:25 am
Novo Nordisk
amycretin
obesity
BMS, AstraZeneca, Novartis Add to 2024 M&A Upswing
BioSpace
Mon, 03/18/24 - 11:10 am
M&A
Bristol Myers Squibb
Novartis
AstraZeneca
Novo Nordisk
Pfizer
Eli Lilly strikes deal with Amazon: Will the ecommerce giant become go-to destination for GLP-1s?
Biopharma Reporter
Mon, 03/18/24 - 11:02 am
Eli Lilly
Novo Nordisk
GLP-1 agonist
Zepbound
Wegovy
Amazon
Asgard Gets $32M Series A Backing from J&J, Novo and Boehringer
BioSpace
Sun, 03/17/24 - 09:25 pm
Asgard Therapeutics
JNJ
Novo Nordisk
Boehringer Ingelheim
funding
immuno-oncology
Lilly weight-loss drug Zepbound new US prescriptions surpass Wegovy for first time
Reuters
Sun, 03/17/24 - 09:17 pm
Eli Lilly
Zepbound
Novo Nordisk
Wegovy
weight loss
J&J, Novo support Asgard’s push to make ‘in vivo’ cell therapies
BioPharma Dive
Thu, 03/14/24 - 11:31 am
Asgard Therapeutics
in vivo cell therapy
cell therapy
JNJ
Novo Nordisk
How the Ozempic gold rush is causing ‘deeply concerning’ shortage for diabetes patients
Biopharma Reporter
Wed, 03/13/24 - 11:16 am
Ozempic
Novo Nordisk
GLP-1
diabetes
drug shortages
Novo Nordisk-owner to expand in India this year
Reuters
Tue, 03/12/24 - 06:50 pm
Novo Nordisk
Novo Holdings
India
Novo Nordisk working with global authorities to take down fake Ozempic
Beckers Hospital Review
Mon, 03/11/24 - 05:03 pm
Novo Nordisk
drug counterfeiting
Ozempic
FDA clears use of Novo’s obesity drug to protect heart health
BioPharma Dive
Sun, 03/10/24 - 08:43 pm
Novo Nordisk
FDA
Wegovy

Pages